Nifedipine facilitates neurotransmitter release independently of calcium channels

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 10, 2003, Pages 6139-6144

  Hirasawa, Michiru ^a   Pittman, Quentin J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CADMIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIHYDROPYRIDINE DERIVATIVE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLUTAMIC ACID; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NITRIC OXIDE; PROTEIN KINASE C; TETRODOTOXIN; THAPSIGARGIN; VERAPAMIL;

ANGINA PECTORIS; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; HYPERTENSION; MALE; MOUSE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SYNAPSE;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; BRAIN; CADMIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; EGTAZIC ACID; KINETICS; MALE; NEUROTRANSMITTER AGENTS; NIFEDIPINE; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; THAPSIGARGIN;

ANGINA; ANIMALIA;

EID: 0037598770     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0936131100     Document Type: Article

References (42)

1. Janicki, P. K., Siembab, D., Paulo, E. A. & Krzascik, P. (1988) Pharmacology 36, 183-187.
2. McKinney, R. A., Capogna, M., Durr, R., Gahwiler, B. H. & Thompson, S. M. (1999) Nat. Neurosci. 2, 44-49.
3. Saitoe, M., Schwarz, T. L., Umbach, J. A., Gundersen, C. B. & Kidokoro, Y. (2001) Science 293, 514-517.
4. Murthy, V. N., Sejnowski, T. J. & Stevens, C. F. (2000) Proc. Natl. Acad. Sci. USA 97, 901-906.
5. Kombian, S. B., Hirasawa, M., Mouginot, D., Chen, X. & Pittman, Q. J. (2000) J. Neurophysiol. 83, 2542-2553.
6. Khvotchev, M., Lonart, G. & Sudhof, T. C. (2000) Neuroscience 101, 793-802.
7. Capogna, M., Gahwiler, B. H. & Thompson, S. M. (1996) J. Neurophysiol. 76, 3149-3158.
8. Trudeau, L. E., Doyle, R. T., Emery, D. G. & Haydon, P. G. (1996) J. Neurosci. 16, 46-54.
9. Armstrong, W. E. (1995) Prog. Neurobiol. 47, 291-339.
10. Tasker, J. G., Hoffman, N. W. & Dudek, F. E. (1991) J. Neurosci. Methods 38, 129-143.
11. Edwards, F. A., Konnerth, A. & Sakmann, B. (1990) J. Physiol. (London) 430, 213-249.
12. Sanguinetti, M. C. & Kass, R. S. (1984) Biophys. J. 45, 873-880.
13. Diaz-Araya, G., Godoy, L., Naranjo, L., Squella, J. A., Letelier, M. E. & Nunez-Vergara, L. J. (1998) Gen. Pharmacol. 31, 385-391.
14. Llano, I., Gonzalez, J., Caputo, C., Lai, F. A., Blayney, L. M., Tan, Y. P. & Marty, A. (2000) Nat. Neurosci. 3, 1256-1265.
15. Druzin, M., Haage, D., Malinina, E. & Johansson, S. (2002) J. Physiol. (London) 542, 131-146.
16. Charles, A. C. & Hales, T. G. (1995) J. Neurophysiol. 73, 56-64.
17. Zernig, G. (1990) Trends Pharmacol. Sci. 11, 38-44.
18. Morgan, P. F., Tamborska, E., Patel, J. & Marangos, P. J. (1987) Neuropharmacology 26, 1693-1699.
19. Oliet, S. H. & Poulain, D. A. (1999) J. Physiol. (London) 520, 815-825.
20. Dhein, S., Salameh, A., Berkels, R. & Klaus, W. (1999) Drugs 58, 397-404.
21. Ozaki, M., Shibuya, I., Kabashima, N., Isse, T., Noguchi, J., Ueta, Y., Inoue, Y., Shigematsu, A. & Yamashita, H. (2000) J. Neuroendocrinol. 12, 273-281.
22. Cummings, D. D., Wilcox, K. S. & Dichter, M. A. (1996) J. Neurosci. 16, 5312-5323.
23. Grassi, F., Mileo, A. M., Monaco, L., Punturieri, A., Santoni, A. & Eusebi, F. (1994) Brain Res. 659, 226-230.
24. Weigl, L. G., Hohenegger, M. & Kress, H. G. (2000) J. Physiol. (London) 525, 461-469.
25. Adler, E. M., Augustine, G. J., Duffy, S. N. & Charlton, M. P. (1991) J. Neurosci. 11, 1496-1507.
26. Robitaille, R., Garcia, M. L., Kaczorowski, G. J. & Charlton, M. P. (1993) Neuron 11, 645-655.
27. Chen, C. & Regehr, W. G. (1997) J. Neurosci. 17, 8687-8694.
28. Chavez-Noriega, L. E. & Stevens, C. F. (1994) J. Neurosci. 14, 310-317.
29. Evans, D. I., Jones, R. S. & Woodhall, G. (2001) J. Neurophysiol. 85, 571-579.
30. Soliakov, L. & Wonnacott, S. (2001) Br. J. Pharmacol. 132, 785-791.
31. Stevens, C. F. & Sullivan, J. M. (1998) Neuron 21, 885-893.
32. Shi, S. H., Hayashi, Y., Petralia, R. S., Zaman, S. H., Wenthold, R. J., Svoboda, K. & Malinow, R. (1999) Science 284, 1811-1816.
33. Lu, W., Man, H., Ju, W., Trimble, W. S., MacDonald, J. F. & Wang, Y. T. (2001) Neuron 29, 243-254.
34. Passafaro, M., Piech, V. & Sheng, M. (2001) Nat. Neurosci. 4, 917-926.
35. Broutman, G. & Baudry, M. (2001) J. Neurosci. 21, 27-34.
36. Rovnyak, G. C., Kimball, S. D., Beyer, B., Cucinotta, G., DiMarco, J. D., Gougoutas, J., Hedberg, A., Malley, M., McCarthy, J. P., Zhang, R. et al. (1995) J. Med. Chem. 38, 119-129.
37. Bangalore, R., Baindur, N., Rutledge, A., Triggle, D. J. & Kass, R. S. (1994) Mol. Pharmacol. 46, 660-666.
38. van Zwieten, P. A. (1998) Blood Press. Suppl. 2, 5-9.
39. Aiello, M., Moran, O., Pisciotta, M. & Gambale, F. (1998) Eur. Biophys. J. 27, 211-218.
40. Foster, T. S., Hamann, S. R., Richards, V. R., Bryant, P. J., Graves, D. A. & McAllister, R. G. (1983) J. Clin. Pharmacol. 23, 161-170.
41. Binggeli, C, Corti, R., Sudano, I., Luscher, T. F. & Noll, G. (2002) Hypertension 39, 892-896.
42. Medina, P., Acuna, A., Martinez-Leon, J. B., Otero, E., Vila, J. M., Aldasoro, M. & Lluch, S. (1998) Circulation 97, 865-870.